Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Miller

Showing results (231-240 of 290) with videos related to

Pageof 29
Sort By:
The Journal of Urology|July 27, 2011
A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancerE David Crawford, Bertrand Tombal, Kurt Miller, et al.
Oncology|January 6, 2009
Germ cell tumors of the gonads: a selective review emphasizing problems in drug resistance and current therapy optionsMark Schrader, Carsten Kempkensteffen, Frank Christoph, et al.
BMC Medical Informatics and Decision Making|August 7, 2013
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité BerlinDaniel Baumunk, Roman Reunkoff, Julien Kushner, et al.
BMC Cancer|August 12, 2009
Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancerCarsten Kempkensteffen, Florian Rudolf Fritzsche, Manfred Johannsen, et al.
Der Urologe. Ausg. A|August 18, 2021
[Interdisciplinary expert consensus on innovations in imaging diagnostics and radionuclide-based therapies for advanced prostate cancer]Dirk Beyersdorff, Kambiz Rahbar, Markus Essler, et al.
Urologia Internationalis|September 1, 2016
Long-Term Donor Outcomes after Pure Laparoscopic versus Open Living Donor Nephrectomy: Focus on Pregnancy Rates, Hypertension and Quality of LifeFrank Friedersdorff, Lisa Kothmann, Philipp Manus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancerKarim Fizazi, Karim S Fizazi, Celestia S Higano, et al.
Aktuelle Urologie|June 14, 2019
[The Onkonet database: taking stock of an Internet-based, multi-centre database on surgical prostate cancer treatment]Margit Pohle, Ahmed Magheli, Wolfgang Diederichs, et al.
Journal of Clinical Medicine|February 15, 2022
Kidney Perfusion in Contrast-Enhanced Ultrasound (CEUS) Correlates with Renal Function in Living Kidney DonorsNasrin El-Bandar, Markus H Lerchbaumer, Robert Peters, et al.
The Lancet. Oncology|July 31, 2016
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trialFred Saad, Joan Carles, Silke Gillessen, et al.
Pageof 29

Showing results (231-240 of 290) with videos related to

Sort By:
Pageof 29
The Journal of Urology|July 27, 2011
A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancerE David Crawford, Bertrand Tombal, Kurt Miller, et al.
Oncology|January 6, 2009
Germ cell tumors of the gonads: a selective review emphasizing problems in drug resistance and current therapy optionsMark Schrader, Carsten Kempkensteffen, Frank Christoph, et al.
BMC Medical Informatics and Decision Making|August 7, 2013
Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité BerlinDaniel Baumunk, Roman Reunkoff, Julien Kushner, et al.
BMC Cancer|August 12, 2009
Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancerCarsten Kempkensteffen, Florian Rudolf Fritzsche, Manfred Johannsen, et al.
Der Urologe. Ausg. A|August 18, 2021
[Interdisciplinary expert consensus on innovations in imaging diagnostics and radionuclide-based therapies for advanced prostate cancer]Dirk Beyersdorff, Kambiz Rahbar, Markus Essler, et al.
Urologia Internationalis|September 1, 2016
Long-Term Donor Outcomes after Pure Laparoscopic versus Open Living Donor Nephrectomy: Focus on Pregnancy Rates, Hypertension and Quality of LifeFrank Friedersdorff, Lisa Kothmann, Philipp Manus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancerKarim Fizazi, Karim S Fizazi, Celestia S Higano, et al.
Aktuelle Urologie|June 14, 2019
[The Onkonet database: taking stock of an Internet-based, multi-centre database on surgical prostate cancer treatment]Margit Pohle, Ahmed Magheli, Wolfgang Diederichs, et al.
Journal of Clinical Medicine|February 15, 2022
Kidney Perfusion in Contrast-Enhanced Ultrasound (CEUS) Correlates with Renal Function in Living Kidney DonorsNasrin El-Bandar, Markus H Lerchbaumer, Robert Peters, et al.
The Lancet. Oncology|July 31, 2016
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trialFred Saad, Joan Carles, Silke Gillessen, et al.
Pageof 29